Navigating systemic therapy for metastatic castration-naïve prostate cancer

被引：0
|
作者：
E. M. Kwan
I. A. Thangasamy
J. Teh
O. Alghazo
N. J. Sathianathen
N. Lawrentschuk
A. A. Azad
机构：
[1] Monash University,Department of Medicine, School of Clinical Sciences
[2] Monash Health,Department of Medical Oncology
[3] University of Melbourne,Division of Cancer Surgery, Peter MacCallum Cancer Centre
[4] University of Queensland,Faculty of Medicine
[5] University of Melbourne,Department of Surgery
[6] Austin Hospital,Department of Medical Oncology
[7] Peter MacCallum Cancer Centre,Sir Peter MacCallum Department of Oncology
[8] University of Melbourne,undefined
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Metastatic prostate cancer; Castration-naïve; Hormone-sensitive; Androgen receptor pathway inhibitors; Docetaxel; Abiraterone; Enzalutamide; Apalutamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：339 / 348
页数：9
相关论文
共 50 条
  • [1] Identification of functional and diverse circulating cancer-associated fibroblasts in metastatic castration-naïve prostate cancer patients
    Booijink, Richell
    Terstappen, Leon W. M. M.
    Dathathri, Eshwari
    Isebia, Khrystany
    Kraan, Jaco
    Martens, John
    Bansal, Ruchi
    MOLECULAR ONCOLOGY, 2024,
  • [2] Navigating systemic therapy for metastatic castration-naive prostate cancer
    Kwan, E. M.
    Thangasamy, I. A.
    Teh, J.
    Alghazo, O.
    Sathianathen, N. J.
    Lawrentschuk, N.
    Azad, A. A.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 339 - 348
  • [3] A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer
    Sang Eun Yoon
    Youjin Kim
    Jangho Cho
    Minyong Kang
    Hyun Hwan Sung
    Hwang Gyun Jeon
    Byoung Chang Jeong
    Seong Il Seo
    Seong Soo Jeon
    Hyun Moo Lee
    Han Yong Choi
    Su Jin Lee
    Se Hoon Park
    BMC Urology, 19
  • [4] MULTIVISCERAL SURGERY IN PATIENTS WITH LOCALLY ADVANCED CASTRATION-NAÏVE AND CASTRATION-RESISTANT, SYMPTOMATIC PROSTATE CANCER
    Heidenreich, Julian
    Paffenholz, Pia
    Pfister, David
    Rieger, Constantin
    Heidenreich, Axel
    JOURNAL OF UROLOGY, 2025, 213 (5S):
  • [5] A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer
    Seonggyu Byeon
    Hongsik Kim
    Hwang Gyun Jeon
    Seong Il Seo
    Seong Soo Jeon
    Hyun Moo Lee
    Soon Il Lee
    Se Hoon Park
    BMC Cancer, 21
  • [6] Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer
    Grisay, Guillaume
    Lavaud, Pernelle
    Fizazi, Karim
    CURRENT ONCOLOGY REPORTS, 2024, 26 (05) : 488 - 495
  • [7] Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer
    Galletti, Giuseppe
    Leach, Benjamin I.
    Lam, Linda
    Tagawa, Scott T.
    CANCER TREATMENT REVIEWS, 2017, 57 : 16 - 27
  • [8] Enzalutamide: A Review of Its Use in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
    Gillian M. Keating
    Drugs & Aging, 2015, 32 : 243 - 249
  • [9] PRESCRIPTION PATTERNS OF SYSTEMIC THERAPY IN THE MANAGEMENT OF METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
    Black, Joseph
    Einstein, David
    Gao, Xin
    Wei, Xiao
    Connell, Brendan
    Kamkari, Nick
    Gershman, Boris
    Olumi, Aria
    JOURNAL OF UROLOGY, 2023, 209 : E123 - E123
  • [10] Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review
    Loblaw, D. A.
    Walker-Dilks, C.
    Winquist, E.
    Hotte, S. J.
    CLINICAL ONCOLOGY, 2013, 25 (07) : 406 - 430
12345